Limits...
Characterizing the assessment and management of vitamin d levels in patients with osteoporosis in clinical practice: a chart review initiative.

Adachi JD, Brown JP, Ioannidis G - J Osteoporos (2015)

Bottom Line: Physicians also evaluated patients' current regimens and detailed proposed changes, if applicable.Nearly 85% of patients were prescribed calcium and vitamin D supplements.Serum 25-hydroxy vitamin D levels were available for 73% of patients.

View Article: PubMed Central - PubMed

Affiliation: Charlton Medical Centre, Department of Medicine, McMaster University, 25 Charlton Avenue E., Suite 501, Hamilton, ON, Canada L8N 1Y2.

ABSTRACT
Though vitamin D is important for bone health, little is known about the monitoring and management of vitamin D levels in patients with osteoporosis in clinical practice-a deficit this chart review initiative aimed to remedy. A total of 52 physicians completed profiles for 983 patients being treated for osteoporosis between November 2008 and April 2009. Information collected included demographics; fracture risk factors; availability and level of serum vitamin D measurements; and information on osteoporosis medications and calcium and vitamin D supplementation. Physicians also evaluated patients' current regimens and detailed proposed changes, if applicable. Nearly 85% of patients were prescribed calcium and vitamin D supplements. Serum 25-hydroxy vitamin D levels were available for 73% of patients. Of these patients, approximately 50% had levels less than 80 nmol/L, which contrasts with the 37% thought to have "unsatisfactory" vitamin D levels based on physician perceptions. Physicians felt 26% of patients would benefit from additional vitamin D supplementation. However, no changes to the osteoporosis regimen were suggested for 48% of patients perceived to have "unsatisfactory" vitamin D levels. The results underscore the importance of considering vitamin D status when looking to optimize bone health.

No MeSH data available.


Related in: MedlinePlus

Serum 25(OH)D levels by prescribed level of vitamin D supplementation (n = 718). Note: numbers may not add to 100 due to rounding.
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4325965&req=5

fig3: Serum 25(OH)D levels by prescribed level of vitamin D supplementation (n = 718). Note: numbers may not add to 100 due to rounding.

Mentions: Serum 25(OH)D levels were available in charts for 61.2% (n/N = 602/983) of patients and were measured during the course of the initiative for a further 11.8% (n/N = 116/983) of patients, meaning serum 25(OH)D levels were available for 73.0% (n/N = 718/983) of patients. In those patients for whom measurements were available, the mean serum 25(OH)D level (SD) was 85.0 (29.0) nmol/L and approximately half of these patients had levels less than 80 nmol/L (see Figure 2). Over 60% (n/N = 136/215) of patients prescribed less than 2800 IU/week of vitamin D had serum 25(OH)D levels less than 80 nmol/L, as compared to 46% (n/N = 68/147) and 37% (n/N = 133/356) of those prescribed 2800–5599 IU/week and at least 5600 IU/week, respectively (see Figure 3).


Characterizing the assessment and management of vitamin d levels in patients with osteoporosis in clinical practice: a chart review initiative.

Adachi JD, Brown JP, Ioannidis G - J Osteoporos (2015)

Serum 25(OH)D levels by prescribed level of vitamin D supplementation (n = 718). Note: numbers may not add to 100 due to rounding.
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4325965&req=5

fig3: Serum 25(OH)D levels by prescribed level of vitamin D supplementation (n = 718). Note: numbers may not add to 100 due to rounding.
Mentions: Serum 25(OH)D levels were available in charts for 61.2% (n/N = 602/983) of patients and were measured during the course of the initiative for a further 11.8% (n/N = 116/983) of patients, meaning serum 25(OH)D levels were available for 73.0% (n/N = 718/983) of patients. In those patients for whom measurements were available, the mean serum 25(OH)D level (SD) was 85.0 (29.0) nmol/L and approximately half of these patients had levels less than 80 nmol/L (see Figure 2). Over 60% (n/N = 136/215) of patients prescribed less than 2800 IU/week of vitamin D had serum 25(OH)D levels less than 80 nmol/L, as compared to 46% (n/N = 68/147) and 37% (n/N = 133/356) of those prescribed 2800–5599 IU/week and at least 5600 IU/week, respectively (see Figure 3).

Bottom Line: Physicians also evaluated patients' current regimens and detailed proposed changes, if applicable.Nearly 85% of patients were prescribed calcium and vitamin D supplements.Serum 25-hydroxy vitamin D levels were available for 73% of patients.

View Article: PubMed Central - PubMed

Affiliation: Charlton Medical Centre, Department of Medicine, McMaster University, 25 Charlton Avenue E., Suite 501, Hamilton, ON, Canada L8N 1Y2.

ABSTRACT
Though vitamin D is important for bone health, little is known about the monitoring and management of vitamin D levels in patients with osteoporosis in clinical practice-a deficit this chart review initiative aimed to remedy. A total of 52 physicians completed profiles for 983 patients being treated for osteoporosis between November 2008 and April 2009. Information collected included demographics; fracture risk factors; availability and level of serum vitamin D measurements; and information on osteoporosis medications and calcium and vitamin D supplementation. Physicians also evaluated patients' current regimens and detailed proposed changes, if applicable. Nearly 85% of patients were prescribed calcium and vitamin D supplements. Serum 25-hydroxy vitamin D levels were available for 73% of patients. Of these patients, approximately 50% had levels less than 80 nmol/L, which contrasts with the 37% thought to have "unsatisfactory" vitamin D levels based on physician perceptions. Physicians felt 26% of patients would benefit from additional vitamin D supplementation. However, no changes to the osteoporosis regimen were suggested for 48% of patients perceived to have "unsatisfactory" vitamin D levels. The results underscore the importance of considering vitamin D status when looking to optimize bone health.

No MeSH data available.


Related in: MedlinePlus